Jessica Hagen
The company also disclosed that it reached an agreement with most holders of its Series A and Series B warrants to convert those warrants into common stock.
The company says the model excels in healthcare applications, outperforming previous models on real-world clinical tasks and is already being adopted by healthcare companies.
The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.
The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second-quarter earnings.
The acquisition comes just months after Cerebral reached a settlement with the FTC over allegations of deceptive subscription and data-sharing practices.
Synchron announced an ALS patient has become the first person to control an iPad using only his thoughts, thanks to a brain-computer interface and Apple’s BCI protocol.
The company is adding 4,200 clinics to its provider network and enabling cost-sharing as well as direct claims payment to providers and clinicians.
The EU says makers and distributors of health-related app stores or applications will now be considered medical device makers and must adhere to associated regulations.
The company said it plans to expand U.S. access to its services while growing its pipeline to include additional cardiac conditions and new distribution channels.
The tech giant's SensorLM analyzes data from wearables to provide personalized insights into how everyday life affects one's body.